pembrolizumab,entinostat
merck,syndax pharma
['mds', 'pembro', 'entinostat']
congress | #eha2023 | poster jan bewersdorf, highlights a phase ib trial assessing the safety and efficacy of entinostat + pembrolizumab in pts with #mds after hma failure. entinostat + pembrolizumab at dose level 1 was safe but efficacy was limited. 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm